TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
FDA Approval Summary: Retifanlimab for the Treatment of Adult Patients with Metastatic or Inoperable Locally Recurrent Squamous Cell Carcinoma of the Anal Canal.
Shruti U Gandhy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.